Duarte, CA, United States of America

Yu-Lin Su

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu-Lin Su. Retrieved from https://idiyas.com/inventor/yu-lin-su-72c4xlgj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu-Lin Su: Innovator in Therapeutic Applications

Introduction

Yu-Lin Su is a notable inventor based in Duarte, California. She has made significant contributions to the field of therapeutic agents, particularly through her innovative research and patent work.

Latest Patents

Yu-Lin Su holds a patent titled "MicroRNA as a Therapeutic Agent." This patent represents her pioneering efforts in utilizing microRNA for therapeutic purposes, showcasing her commitment to advancing medical science.

Career Highlights

Yu-Lin Su is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work in this esteemed organization highlights her dedication to public health and innovation.

Collaborations

Yu-Lin Su collaborates with Marcin Tomasz Kortylewski, contributing to the advancement of research in their field. Their partnership exemplifies the importance of teamwork in scientific discovery.

Conclusion

Yu-Lin Su's contributions to the field of therapeutic agents through her patent and collaborative efforts underscore her role as an influential inventor. Her work continues to inspire advancements in medical research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…